iTEC as a new experimental system for TEC biology

iTEC 作为 TEC 生物学的新实验系统

基本信息

  • 批准号:
    10493405
  • 负责人:
  • 金额:
    $ 18.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-22 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The thymus is the key organ required for T cell generation and the formation of an adaptive immune response. One key cell type, endoderm-derived thymic epithelium, is required both for all thymus functions and to orchestrate the assembly and differentiation of all other cell types within the thymus. The genetic pathways underlying the specification and differentiation of these thymic epithelial cells (TECs) are still poorly understood. However, a single transcription factor, FOXN1, is known to control multiple key aspects of TEC proliferation, differentiation, and maintenance in both the fetal and postnatal thymus. Work from our lab and others has shown that Foxn1 acts differentially in TEC subsets and is incredibly dosage-sensitive, and that its expression in TEC progenitors is sufficient to drive most if not all of the TEC differentiation program. Because of this central role, Foxn1 is a key target in ongoing efforts to generate TEC by the directed differentiation of induced pluripotent stem cells (iPSCs). However, many questions remain about the precise FOXN1 functions in TEC differentiation and proliferation. While at least some of the FOXN1 targets required for TEC function are known, key questions remain unanswered, including the molecular pathways that establish TEC identity and initiate Foxn1 expression, and how diverse levels of FOXN1 in different TEC subsets differentially control TEC biology. We were part of a collaborative team that showed that enforced expression of FOXN1 in murine embryonic fibroblasts (MEFs) is sufficient to convert MEFs into functional TEC. These “induced TECs” (iTECs) can, upon transplantation, direct the assembly of a fully functional thymus organ that supports development of T cells in vivo. iTECs also show promise in promoting differentiation of immature thymocytes into single positive T cells in 2-dimensional culture. iTECs may thus provide a novel tool for long-term goals of generating autologous TEC in vitro that could be used to generate organoids for transplant, or for in vitro generation of T cells for therapeutic purposes. More broadly, the field of thymus biology lacks a viable in vitro culture system for studying the molecular requirements for TEC biology and differentiation, or TEC-thymocyte interactions that direct T cell development and selection. iTECs thus could provide a useful in vitro system for studying both FOXN1 function and the genetic pathways that control TEC differentiation and function. This proposal is designed to address key aspects of iTEC generation that limit its broader adoption as an experimental system. We propose three specific aims focused on improving the control of iTEC differentiation and proliferation that will allow us to develop this method for broad experimental applications: 1) Foxn1 dosage sensitivity during iTEC generation; 2) mechanisms to promote mTEC differentiation in iTEC cultures; and 3) MHCII expression and iTEC proliferation. Successful completion of the proposed experiments will substantially improve iTEC generation and function, with the goal of establishing iTECs as into a much-needed in vitro experimental system with broad utility for studying FOXN1 function and TEC biology, T cell differentiation, and TEC-thymocyte interactions.
项目总结/摘要 胸腺是T细胞生成和形成适应性免疫反应所需的关键器官。 一种关键的细胞类型,内胚层来源的胸腺上皮细胞,是所有胸腺功能所必需的, 协调胸腺内所有其他细胞类型的组装和分化。遗传途径 这些胸腺上皮细胞(TEC)的特化和分化的基础仍然知之甚少。 然而,已知单个转录因子FOXN 1控制TEC增殖的多个关键方面, 分化和维持在胎儿和出生后胸腺。我们实验室和其他机构的研究表明 Foxn 1在TEC亚群中的作用不同,并且具有令人难以置信的剂量敏感性, 祖细胞足以驱动大多数(如果不是全部的话)TEC分化程序。由于这一核心作用, Foxn 1是通过诱导多能造血干细胞定向分化产生TEC的持续努力中的关键靶点。 干细胞(iPSC)。然而,关于FOXN 1在TEC分化中的确切功能仍存在许多问题 和扩散。虽然TEC功能所需的至少一些FOXN 1目标是已知的,但关键问题是 仍然没有答案,包括建立TEC身份和启动Foxn 1表达的分子途径, 以及FOXN 1在不同TEC亚群中的不同水平如何不同地控制TEC生物学。我们是 一个合作小组的研究表明,FOXN 1在鼠胚胎成纤维细胞(MEFs)中的强制表达, 足以将MEF转化为功能性TEC。这些“诱导的TEC”(iTEC)可以在移植后直接 在体内支持T细胞发育的功能齐全的胸腺器官的组装。iTEC还显示, 有望在二维培养中促进未成熟胸腺细胞分化为单个阳性T细胞。 因此,iTEC可以为体外产生自体TEC的长期目标提供一种新的工具, 以产生用于移植的类器官,或用于治疗目的的T细胞的体外产生。更广泛地说, 胸腺生物学领域缺乏用于研究TEC的分子需求的可行的体外培养系统 生物学和分化,或指导T细胞发育和选择的TEC-胸腺细胞相互作用。iTECs 因此,可以提供一个有用的体外系统,用于研究FOXN 1的功能和遗传途径, 控制TEC分化和功能。该提案旨在解决iTEC生成的关键问题 这限制了它作为实验系统的广泛采用。我们提出了三个具体目标,重点是改善 iTEC分化和增殖的控制将使我们能够开发这种方法用于广泛的实验 应用:1)iTEC生成期间的Foxn 1剂量敏感性; 2)促进mTEC的机制 iTEC培养物中的分化;和3)MHCII表达和iTEC增殖。成功完成 拟议的实验将大大改善iTEC的生成和功能,目标是建立 iTECs作为一个急需的体外实验系统,具有广泛的实用性,用于研究FOXN 1功能, TEC生物学、T细胞分化和TEC-胸腺细胞相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nancy R Manley其他文献

Foxn1 is required for thymic vascularization
Foxn1 是胸腺血管形成所必需的
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takuya Saiki;Kei Mukohara Takashi Otani;Nobutaro Ban.;T.Kaisho;改正恒康;Nancy R Manley
  • 通讯作者:
    Nancy R Manley
CASA: A new method for quantifying organization
CASA:一种量化组织的新方法
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawakami M;Morita S;Sunohara M;Amano Y;Ishikawa R;Watanabe K;Hamano E;Ohishi N;Nakajima J;Yatomi Y;Nagase T;Fukayama M;Takai D.;井手均,岩瀬正典,中村宇大,藤井裕樹,大隈俊明,城臺環,筒信隆,布井清秀,五島大祐,野原栄,篠原規恭,南昌江,和田美也,横溝由史,菊池正統,野見山理久,中村晋,田代憲司,吉成元孝,北園孝成;Nancy R Manley
  • 通讯作者:
    Nancy R Manley
Foxnl is required for thymic vascularization
Foxnl 是胸腺血管化所必需的
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Iwasaki;Y.;et al.;高浜洋介;織田順;善本知広;改正恒康;赤松園子・服部淳子・西原みゆき・山口佳子・岡崎章;Nancy R Manley
  • 通讯作者:
    Nancy R Manley

Nancy R Manley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nancy R Manley', 18)}}的其他基金

iTEC as a new experimental system for TEC biology
iTEC 作为 TEC 生物学的新实验系统
  • 批准号:
    10373479
  • 财政年份:
    2021
  • 资助金额:
    $ 18.88万
  • 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
  • 批准号:
    10022938
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
  • 批准号:
    10251298
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Identifying new genes involved in thymic involution
鉴定参与胸腺退化的新基因
  • 批准号:
    9909275
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Identifying new genes involved in thymic involution
鉴定参与胸腺退化的新基因
  • 批准号:
    10092939
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
  • 批准号:
    10689296
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
  • 批准号:
    10470931
  • 财政年份:
    2020
  • 资助金额:
    $ 18.88万
  • 项目类别:
Project 1: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
项目 1:T 细胞衰老和再生的胸腺和外周方面
  • 批准号:
    10226921
  • 财政年份:
    2017
  • 资助金额:
    $ 18.88万
  • 项目类别:
Mouse models for TB infection across the lifespan
整个生命周期的结核感染小鼠模型
  • 批准号:
    8772193
  • 财政年份:
    2014
  • 资助金额:
    $ 18.88万
  • 项目类别:
Molecular mechanisms and epigenetic signatures that specify thymus fate
决定胸腺命运的分子机制和表观遗传特征
  • 批准号:
    9436424
  • 财政年份:
    2014
  • 资助金额:
    $ 18.88万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.88万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 18.88万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 18.88万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了